The role of the pharmacist in the treatment of pediatric patients with infantile hemangioma using propranolol
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: CASTANEDA, Saul (UABC, Pharmacy, Chula Vista, United States)
- Co-author(s): Saul Castaneda: Pharmacy, UABC, Tijuana, United States
Jose Luis Sanchez Palacio: Pharmacy, UABC, Tijuana, United States
Hermelinda De la Cruz Duran: Pharmacy, Hospital Infantil de las Californias, Tijuana, Mexico
Infantile hemangioma (IH) is the most common benign vascular tumors of childhood. Propranolol is considered the first-line treatment for this condition. Potentially there is a high probability of negative results to therapy, because in many countries there are no treatment protocols or propranolol formulations appropriate for the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.